Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era
Sadaf Ataei-Alamdari, Fatemeh Alimardani, Hamed Afkhami, Mojtaba Kashfi, Mohammad Hasan Yousefi · 2026
Read Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era by Sadaf Ataei-Alamdari, Fatemeh Alimardani, Hamed Afkhami, Mojtaba Kashfi, Mohammad Hasan Yousefi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13325734.txt.
Description
Sadaf Ataei-Alamdari and colleagues review pairing probiotics with bacteria-killing viruses against drug-resistant infections in a 2026 article. Resistant germs were tied to 4.71 million deaths in 2021 and could reach 10 million a year by 2050 on current trends.
Probiotics shore up the host microbe community while phages strike target pathogens directly, so the pair attacks on two fronts. The review weighs how the two interact at the molecular level, their safety records, and their fit for clinic use. Hurdles include product formulation, delivery to the infection site, and regulation. The authors frame the pairing as a tailored, microbiome-friendly route for the post-antibiotic era.
Catalog record
| CREATOR | Sadaf Ataei-Alamdari, Fatemeh Alimardani, Hamed Afkhami, Mojtaba Kashfi, Mohammad Hasan Yousefi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79875 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |